Payment overview · 2025
General Payments
$156.23
2 reported records · 1 companies
Healthcare provider profile · identity verified
Arshea Siddiqui, MD
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · AURORA, IL · NPI 1184670671
Verified facts
What the public records show
CMS Open Payments records show Arshea Siddiqui, MD received $156.23 in general payments during 2025 across 2 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $156.23 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $156.23 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $156.23 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1238 | 185 |
| Levothyroxine Sodium | Levothyroxine Sodium | 972 | 145 |
| Furosemide | Furosemide | 807 | 130 |
| Potassium Chloride | Potassium Chloride | 798 | 132 |
| Amlodipine Besylate | Amlodipine Besylate | 763 | 107 |
| Metoprolol Succinate | Metoprolol Succinate | 661 | 108 |
| Memantine Hcl | Memantine Hcl | 571 | 99 |
| Omeprazole | Omeprazole | 513 | 95 |
| Eliquis | Apixaban | 508 | 76 |
| Donepezil Hcl | Donepezil Hcl | 478 | 73 |
| Escitalopram Oxalate | Escitalopram Oxalate | 472 | 84 |
| Gabapentin | Gabapentin | 400 | 69 |
| Losartan Potassium | Losartan Potassium | 390 | 63 |
| Sertraline Hcl | Sertraline Hcl | 386 | 54 |
| Lisinopril | Lisinopril | 373 | 57 |
| Metoprolol Tartrate | Metoprolol Tartrate | 365 | 51 |
| Quetiapine Fumarate | Quetiapine Fumarate | 341 | 58 |
| Pantoprazole Sodium | Pantoprazole Sodium | 308 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 257 | 50 |
| Clopidogrel | Clopidogrel Bisulfate | 255 | 34 |
| Mirtazapine | Mirtazapine | 248 | 50 |
| Carvedilol | Carvedilol | 217 | 35 |
| Trazodone Hcl | Trazodone Hcl | 216 | 39 |
| Metformin Hcl | Metformin Hcl | 192 | 28 |
| Allopurinol | Allopurinol | 187 | 28 |
| Xarelto | Rivaroxaban | 187 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 172 | 27 |
| Torsemide | Torsemide | 172 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 165 | 16 |
| Latanoprost | Latanoprost | 162 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 157 | 22 |
| Glipizide | Glipizide | 151 | 24 |
| Famotidine | Famotidine | 150 | 24 |
| Methenamine Hippurate | Methenamine Hippurate | 145 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 129 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 128 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 126 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 124 | 25 |
| Ezetimibe | Ezetimibe | 118 | 16 |
| Finasteride | Finasteride | 118 | 19 |
| Simvastatin | Simvastatin | 117 | 20 |
| Buspirone Hcl | Buspirone Hcl | 115 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 115 | 21 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 113 | 19 |
| Bumetanide | Bumetanide | 107 | 19 |
| Divalproex Sodium | Divalproex Sodium | 107 | 21 |
| Alendronate Sodium | Alendronate Sodium | 103 | 18 |
| Midodrine Hcl | Midodrine Hcl | 102 | 27 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 95 | 13 |
| Levetiracetam | Levetiracetam | 95 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 94 | 31 |
| Aripiprazole | Aripiprazole | 92 | 12 |
| Warfarin Sodium | Warfarin Sodium | 92 | 12 |
| Jardiance | Empagliflozin | 80 | 13 |
| Nystatin | Nystatin | 80 | 45 |
| Olanzapine | Olanzapine | 80 | 13 |
| Diltiazem 24hr Er | Diltiazem Hcl | 78 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 74 | 20 |
| Prednisone | Prednisone | 69 | 28 |
| Bupropion Xl | Bupropion Hcl | 65 | 11 |
| Topiramate | Topiramate | 63 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 62 | suppressed |
| Myrbetriq | Mirabegron | 62 | suppressed |
| Spironolactone | Spironolactone | 61 | 15 |
| Azithromycin | Azithromycin | 60 | 49 |
| Ondansetron Hcl | Ondansetron Hcl | 59 | 35 |
| Baclofen | Baclofen | 56 | suppressed |
| Levofloxacin | Levofloxacin | 56 | 44 |
| Tramadol Hcl | Tramadol Hcl | 56 | 15 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 55 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 55 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 54 | 41 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 54 | suppressed |
| Digoxin | Digoxin | 52 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 51 | suppressed |
| Cephalexin | Cephalexin | 51 | 32 |
| Tresiba Flextouch U-100 | Insulin Degludec | 50 | suppressed |
| Metolazone | Metolazone | 49 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 49 | 27 |
| Entresto | Sacubitril/Valsartan | 48 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | suppressed |
| Glimepiride | Glimepiride | 47 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 47 | suppressed |
| Meloxicam | Meloxicam | 46 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 46 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 44 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 43 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 43 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 43 | suppressed |
| Alprazolam | Alprazolam | 42 | 13 |
| Hydrocortisone | Hydrocortisone | 42 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Lorazepam | Lorazepam | 41 | 19 |
| Lovastatin | Lovastatin | 41 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 40 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 40 | 17 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 39 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 39 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 38 | 16 |
| Enulose | Lactulose | 38 | suppressed |
| Loperamide | Loperamide Hcl | 38 | 19 |
| Metformin Hcl Er | Metformin Hcl | 38 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 38 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 25 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 38 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | suppressed |
| Glipizide Er | Glipizide | 37 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 37 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 37 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | suppressed |
| Insulin Lispro | Insulin Lispro | 35 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 34 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | suppressed |
| Carbamazepine | Carbamazepine | 33 | suppressed |
| Timolol Maleate | Timolol Maleate | 33 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 32 | suppressed |
| Linzess | Linaclotide | 32 | suppressed |
| Risperidone | Risperidone | 32 | suppressed |
| Nifedipine Er | Nifedipine | 31 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 30 | suppressed |
| Lansoprazole | Lansoprazole | 30 | suppressed |
| Letrozole | Letrozole | 30 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 30 | suppressed |
| Tradjenta | Linagliptin | 30 | suppressed |
| Verapamil Er | Verapamil Hcl | 30 | suppressed |
| Ampicillin Trihydrate | Ampicillin Trihydrate | 29 | 26 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Estradiol | Estradiol | 28 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Sotalol | Sotalol Hcl | 27 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 26 | 20 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 26 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 25 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 24 | suppressed |
| Nystop | Nystatin | 24 | 13 |
| Sevelamer Carbonate | Sevelamer Carbonate | 24 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 23 | suppressed |
| Temazepam | Temazepam | 23 | suppressed |
| Celecoxib | Celecoxib | 22 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Galantamine Er | Galantamine Hbr | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 21 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 21 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 21 | suppressed |
| Multaq | Dronedarone Hcl | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | suppressed |
| Fetzima | Levomilnacipran Hcl | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Rytary | Carbidopa/Levodopa | 19 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 18 | suppressed |
| Leflunomide | Leflunomide | 18 | suppressed |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 15 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 17 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 16 | 13 |
| Metronidazole | Metronidazole | 16 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Admelog Solostar | Insulin Lispro | 15 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Humalog | Insulin Lispro | 15 | suppressed |
| Jantoven | Warfarin Sodium | 15 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Scopolamine | Scopolamine | 15 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 15 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Permethrin | Permethrin | 14 | suppressed |
| Pregabalin | Pregabalin | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Eplerenone | Eplerenone | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Diclofenac Sodium-Misoprostol | Diclofenac Sodium/Misoprostol | 12 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Fluvoxamine Maleate Er | Fluvoxamine Maleate | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Hydroxyurea | Hydroxyurea | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Levocarnitine | Levocarnitine | 12 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Sulindac | Sulindac | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 12 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Calcium Acetate | Calcium Acetate | 11 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 11 | suppressed |
| Disopyramide Phosphate | Disopyramide Phosphate | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 11 | suppressed |
| Tobramycin | Tobramycin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $156.23 · 2 records | Neurocrine BioSciences, Inc. | INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error